We help doctors and pharma companies evaluate cancer drug efficacy using patient microtumors and computer vision
At Pear Bio, we monitor cancer progression of patient-derived tumor samples against potential treatment options. Our microtumor technology recreates core parts of the human tumor microenvironment for accurate lab testing. With the aid of our computer vision algorithms, we measure the impact each treatment has on stopping cancer in its tracks and eliminating the tumor. We can inform physicians on treatment decisions and we provide tools to help pharmaceutical companies develop new therapies. We also analyze tumor samples to identify promising targets for developing new anti-cancer treatments.